IGNITE
21 Dec 2020
IGNITE
ACTRN12619001185156
Adavosertib targeting Cyclin E1 altered high grade serous ovarian cancer (HGSC) | IGNITE
ANZGOG
Cancer Type | Gynaecological |
---|---|
Trial Type | Treatment |
Phase | Phase II |
Age Range | 18 years and older |
Sex | Female |
Tumour Stream | - |
Cancer Stage | All stages |
Anticipated Start Date | 2020-03-01 |
Anticipated End Date | 2023-03-01 |
Hospital | Flinders Medical Centre |
---|---|
Clinical Trial Coordinator | Alex Scott-Hoy |
alex.scott-hoy@sa.gov.au | |
Phone | 08 8204 4830 |
Principal Investigator | Dr Ganessan Kichenadasse |
Recruitment Status | Not Yet Recruiting |